- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT01196442
Electrical Stimulation Pain Therapy in Treating Chronic Pain and Numbness Caused By Chemotherapy in Patients With Cancer
An Expanded Trial of MC5-A Calmare Therapy in the Treatment of Cancer Pain Syndromes and Chronic Chemotherapy-Induced Peripheral Neuropathy Including Pain and Numbness
Studieöversikt
Status
Intervention / Behandling
Detaljerad beskrivning
OBJECTIVES:
I. To evaluate the effect of MC5-A on pain symptoms both immediately and over time.
II. To evaluate the effect of Calmare therapy on other non-pain symptoms. III. To evaluate the effect of MC5-A on daily opioid and other pain medication use.
OUTLINE: Patients undergo electric stimulation pain therapy comprising MC5-A Calmare therapy over 30 minutes once daily for 10 days. After completion of study treatment, patients are followed up for 3 months.
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
Virginia
-
Richmond, Virginia, Förenta staterna, 23298
- Virginia Commonwealth University
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- CIPN neuropathy: received, or currently receiving, neurotoxic chemotherapy (including taxanes-such as paclitaxel or docetaxel, or platinum-based compounds such as carboplatin or cis-platinum or oxaliplatin, or vinca alkaloids such as vincristine, vinblastine, or vinorelbine, or proteosome inhibitors such as bortezomib)
- Pain or symptoms of peripheral neuropathy of >= 1 months duration attributed to chemotherapy-induced peripheral neuropathy
- OR pain of the other types including chemotherapy-induced peripheral neuropathy, numbness predominant; post mastectomy pain; post surgical pain; post herpetic neuropathy; post radiation pain; other (vertebral compression, fracture, miscellaneous)
- The pain must have been stable for at least 2 weeks
- An average daily pain rating of >= 5 out of 10, using the pain numerical rating scale (NRS: 0 is no pain and 10 is worst pain possible); or numbness that bothers the patient at least "a little bit" on the CIPN-20
- Life expectancy >= 3 months
- ECOG performance status 0, 1, or 2
Exclusion Criteria:
- Pregnant women, nursing women, women of childbearing potential or their sexual partners who are unwilling to employ adequate contraception (condoms, diaphragm, birth control pills, injections, intrauterine device [IUD], surgical sterilization, subcutaneous implants, abstinence, etc.)
- Use of an investigational agent for pain control concurrently or =< 30 days
- History of an allergic reaction or previous intolerance to transcutaneous electronic nerve stimulation
- Patients with implantable drug delivery systems, e.g., Medtronic Synchromed
- Patients with heart stents or metal implants such as pacemakers, automatic defibrillators, aneurysm clips, vena cava clips and skull plates (metal implants for orthopedic repair, e.g., pins, clips, plates, cages, joint replacements are allowed)
- Patients with a history of myocardial infarction or ischemic heart disease within the past six months
- Patients with history of epilepsy, brain damage, use of anti-convulsants, symptomatic brain metastases
- Prior celiac plexus block, or other neurolytic pain control treatment within 4 weeks
- Other identified causes of painful paresthesias existing prior to chemotherapy (e.g., radiation or malignant plexopathy, lumbar or cervical radiculopathy, pre-existing peripheral neuropathy of another etiology: B12 deficiency, AIDS, monoclonal gammopathy, diabetes, heavy metal poisoning amyloidosis, syphilis, hyperthyroidism or hypothyroidism, inherited neuropathy)
- Skin conditions such as open sores that would prevent proper application of the electrodes
- Other medical or other condition(s) that in the opinion of the investigators might compromise the objectives of the study
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Stödjande vård
- Tilldelning: N/A
- Interventionsmodell: Enskild gruppuppgift
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Experimentell: Arm I electric stimulation pain therapy
Patients undergo electric stimulation pain therapy comprising MC5-A Calmare therapy over 30 minutes once daily for 10 days.
|
Electrical stimulation pain therapy for 45 minutes on Day 1, then 30 minutes Days 2-10
Andra namn:
Brief Pain Inventory questionnaire administration at baseline, weekly, then monthly for 3 months
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Change in Pain Score From Day 1 to Day 10
Tidsram: From day 1 to day 10
|
Change in Brief Pain Inventory (Now)Scale 1 (none) to 5 (complete interference) |
From day 1 to day 10
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Effect of Electrical Stimulation Pain Therapy on Other Non-pain Symptoms at Day 1
Tidsram: Day 1
|
Chemotherapy-induced peripheral neuropathy (CIPN)-20.
The CIPN-20 has 3 subscales: a sensory, motor, and autonomic subscale.
There are 17 questions that are rated 0-not at all to 3-very much.
Scales are summed.
Final score ranges from 0-51, 0 as the best possible outcome and 51 as the worst.
|
Day 1
|
Use of Medications Including Morphine Oral Dose Equivalents, Anti-depressants, and Neuroleptics
Tidsram: From day 1 to day 30
|
Record daily pain medication usage and convert all opioids to MOEDs (American Pain Society 2003).
Compare the average daily use prior to day 1 to the average daily use day 30.
Range is 0-none to 240-most
|
From day 1 to day 30
|
Effect of Electric Stimulation Pain Therapy on Other Non-pain Symptoms at Day 10
Tidsram: Day 10
|
Chemotherapy-induced peripheral neuropathy (CIPN)-20.
The CIPN-20 has 3 subscales: a sensory, motor, and autonomic subscale.
There are 17 questions that are rated 0-not at all to 3-very much.
Scales are summed.
Final score ranges from 0-51, 0 as the best possible outcome and 51 as the worst.
|
Day 10
|
Effect of Electric Stimulation Pain Therapy on Other Non-pain Symptoms at Month 1
Tidsram: month 1
|
Chemotherapy-induced peripheral neuropathy (CIPN)-20.
The CIPN-20 has 3 subscales: a sensory, motor, and autonomic subscale.
There are 17 questions that are rated 0-not at all to 3-very much.
Scales are summed.
Final score ranges from 0-51, 0 as the best possible outcome and 51 as the worst.
|
month 1
|
Effect of Electric Stimulation Pain Therapy n Other Non-pain Symptoms at Month 2
Tidsram: month 2
|
Chemotherapy-induced peripheral neuropathy (CIPN)-20.
The CIPN-20 has 3 subscales: a sensory, motor, and autonomic subscale.
There are 17 questions that are rated 0-not at all to 3-very much.
Scales are summed.
Final score ranges from 0-51, 0 as the best possible outcome and 51 as the worst.
|
month 2
|
Effect of Electric Stimulation Pain Therapy on Other Non-pain Symptoms at Month 3
Tidsram: Month 3
|
Chemotherapy-induced peripheral neuropathy (CIPN)-20.
The CIPN-20 has 3 subscales: a sensory, motor, and autonomic subscale.
There are 17 questions that are rated 0-not at all to 3-very much.
Scales are summed.
Final score ranges from 0-51, 0 as the best possible outcome and 51 as the worst.
|
Month 3
|
Samarbetspartners och utredare
Sponsor
Utredare
- Huvudutredare: Craig Swainey, MD, Virginia Commonwealth University
Publikationer och användbara länkar
Användbara länkar
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- MCC-13098
- NCI-2010-01945 (Registeridentifierare: CTRP)
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Smärta
-
Korea University Anam HospitalKorea UniversityAvslutadSmärtmätning | Visual Analog Pain Scale
-
Alanya Alaaddin Keykubat UniversityAvslutadSterilisering, Tubal | Visual Analog Pain Scale
-
Turkish Ministry of Health, Kahramanmaras Provincial...RekryteringVisual Analog Pain ScaleKalkon
-
Ankara UniversityAvslutadSmärtmätning | Visual Analog Pain ScaleKalkon
-
East Carolina UniversityIndragen
-
University Hospital, GrenobleAvslutadDövhet | Visual Analog Pain ScaleFrankrike
-
Moens MaartenRekryteringMisslyckad Ryggkirurgi Syndrom | Persistent Spinal Pain Syndrome Typ 2Belgien
-
Moens MaartenVrije Universiteit BrusselRekryteringRyggmärgsstimulering | Persistent Spinal Pain Syndrome Typ 2Belgien
-
Örebro University, SwedenAvslutadPostoperativ smärtintensitet | Rescue Pain KravSverige
-
Wake Forest University Health SciencesRekryteringPhantom Limb Pain (PLP)Förenta staterna
Kliniska prövningar på electrical stimulation pain therapy
-
Phagenesis Ltd.NAMSA; Cytel Inc.RekryteringDysfagiFinland, Schweiz, Österrike, Tyskland
-
US Department of Veterans AffairsAvslutadKardiovaskulär sjukdom | RyggmärgsskadaFörenta staterna
-
Texas Tech University Health Sciences Center, El...RekryteringGastroparesFörenta staterna
-
Spaulding Rehabilitation HospitalAvslutadRyggmärgsskadaFörenta staterna
-
Mayo ClinicAvslutadEssentiell tremor
-
University of MiamiFloridaAvslutadNeuropatisk smärtaFörenta staterna
-
Pain Cure Center, CaliforniaAvslutadNacksmärta | AxelvärkFörenta staterna
-
Universidade Federal de Santa MariaAvslutad
-
Butler HospitalMedtronicAvslutadTvångssyndromFörenta staterna
-
Peking Union Medical College HospitalOkändPrimiparous kvinnor med singelbebis vid terminKina